Lv1
90 积分 2023-09-28 加入
ctDNA-Guided Adjuvant Atezolizumab in Muscle-Invasive Bladder Cancer
2个月前
已完结
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
2个月前
已完结
Circulating tumor DNA clearance as a predictive biomarker of pathologic complete response in patients with solid tumors treated with neoadjuvant immune checkpoint inhibitors: a systematic review and meta-analysis
5个月前
已完结
Adjuvant Durvalumab in Completely Resected Early-Stage Non–Small Cell Lung Cancer
6个月前
已关闭
Risk factors associated with locoregional recurrence following pulmonary segmentectomy for clinical stage IA1-2 NSCLC: a real clinical practice analysis
6个月前
已完结
CT-based Radiologic Ternary Classification Model in Predicting Pathologic Invasiveness of Pulmonary Nonsolid Nodules
6个月前
已完结
Recurrence of Non–Small Cell Lung Cancer With Visceral Pleural Invasion
6个月前
已完结
Facts and Hopes in Neoadjuvant Immunotherapy Combinations in Resectable Non–Small Cell Lung Cancer
6个月前
已完结
Magnetic Resonance Imaging–Detected High-Risk Markers in Rectal Cancer Patients With a Pathologic Complete Response After Neoadjuvant Therapy
7个月前
已关闭
Artificial intelligence for predictive biomarker discovery in immuno-oncology: a systematic review
7个月前
已完结
皖公网安备34019202002308
